/PRNewswire/ Curebase, a company committed to democratizing access to clinical studies, capped off a successful 2022 with continued growth, maturity, and.
/PRNewswire/ Curebase, a company committed to democratizing access to clinical studies, has named Lars-Olof "Lollo" Eriksson to its Advisory Board. Eriksson.